Lawrence Green Selected Research

glycopyrronium tosylate

5/2020	Long-term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44-week open-label extension study.
8/2019	A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
1/2019	Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
1/2019	Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lawrence Green Research Topics

Disease

6	Acne Vulgaris 09/2022 - 09/2009
5	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 03/2002
5	Hyperhidrosis 06/2020 - 01/2019
2	Hyperpigmentation 06/2022 - 05/2010
2	Erythema 06/2022 - 05/2012
2	Pain (Aches) 12/2017 - 03/2010
2	Pruritus (Itching) 12/2017 - 05/2012
1	Overweight 09/2022
1	Dermatitis 06/2022
1	Contact Dermatitis (Eczema, Contact) 06/2022
1	Nausea 01/2022
1	Diarrhea 01/2022
1	Headache (Headaches) 01/2022
1	Nasopharyngitis 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Wells syndrome 01/2018
1	Skin Neoplasms (Skin Cancer) 10/2012
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Stroke (Strokes) 11/2003

Drug/Important Bio-Agent (IBA)

6	tazarotene (Tazorac)FDA Link 09/2022 - 03/2002
4	Cholinergic Antagonists (Anticholinergics)IBA 06/2020 - 01/2019
4	glycopyrronium tosylateIBA 05/2020 - 01/2019
3	RetinoidsIBA 06/2022 - 07/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 03/2002
2	secukinumabIBA 02/2020 - 12/2017
2	Clindamycin (Cleocin)FDA LinkGeneric 05/2012 - 09/2009
2	Adapalene (Differin)FDA LinkGeneric 05/2012 - 05/2010
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2022
1	halobetasol (ulobetasol)FDA LinkGeneric 06/2022
1	Therapeutic UsesIBA 06/2022
1	apremilastIBA 01/2022
1	BromidesIBA 06/2020
1	brodalumabIBA 02/2020
1	ixekizumabIBA 02/2020
1	Interleukin-17 (Interleukin 17)IBA 02/2020
1	Interleukin-17 ReceptorsIBA 02/2020
1	Pharmaceutical PreparationsIBA 02/2020
1	CytokinesIBA 02/2020
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 08/2019
1	Thimerosal (Thiomersal)IBA 01/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018
1	Botulinum Toxins (Botulinum Toxin)IBA 10/2012
1	Benzoyl Peroxide FDA LinkGeneric 05/2012
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 07/2011
1	Dapsone FDA Link 07/2011
1	Lidocaine (Xylocaine)FDA LinkGeneric 03/2010
1	Dermal FillersIBA 03/2010
1	Durapatite (Hydroxylapatite)IBA 03/2010
1	CalciumIBA 03/2010
1	2- crotonyloxymethyl- (4R,5R,6R)- 4,5,6- trihydroxycyclohex- 2-enone (COTC)IBA 01/2009
1	Ointments (Pastes)IBA 03/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 07/2011
1	Aftercare (After-Treatment) 06/2022
1	Operative Surgical Procedures 10/2012
1	Injections 10/2012
1	Lasers (Laser) 10/2012
1	Carotid Endarterectomy 11/2003